Abstract
Highly conserved PenI-type class A β-lactamase in pathogenic members of Burkholderia species can evolve to extended-spectrum β-lactamase (ESBL), which exhibits hydrolytic activity toward third-generation cephalosporins, while losing its activity toward the original penicillin substrates. We describe three single-amino-acid-substitution mutations in the ArgS arginine-tRNA synthetase that confer extra antibiotic tolerance protection to ESBL-producing Burkholderia thailandensis. This pathway can be exploited to evade antibiotic tolerance induction in developing therapeutic measures against Burkholderia species, targeting their essential aminoacyl-tRNA synthetases.
Original language | English |
---|---|
Article number | e02252-19 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 64 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2020 Jun |
Keywords
- Antibiotic tolerance
- ArgS
- Arginine-tRNA synthetase
- Stringent response
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases